- Home
- CNTB vs PNI Comparison
CNTB vs PNI Comparison
Compare CNTB & PNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- PNI
- Stock Information
- Founded
- CNTB 2012
- PNI 2002
- Country
- CNTB United States
- PNI United States
- Employees
- CNTB N/A
- PNI N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- PNI Trusts Except Educational Religious and Charitable
- Sector
- CNTB Health Care
- PNI Finance
- Exchange
- CNTB Nasdaq
- PNI Nasdaq
- Market Cap
- CNTB 54.4M
- PNI 75.2M
- IPO Year
- CNTB 2021
- PNI N/A
- Fundamental
- Price
- CNTB $1.46
- PNI $6.67
- Analyst Decision
- CNTB Strong Buy
- PNI
- Analyst Count
- CNTB 2
- PNI 0
- Target Price
- CNTB $7.50
- PNI N/A
- AVG Volume (30 Days)
- CNTB 148.9K
- PNI 26.4K
- Earning Date
- CNTB 09-04-2025
- PNI 01-01-0001
- Dividend Yield
- CNTB N/A
- PNI 4.76%
- EPS Growth
- CNTB N/A
- PNI N/A
- EPS
- CNTB N/A
- PNI N/A
- Revenue
- CNTB $26,033,000.00
- PNI N/A
- Revenue This Year
- CNTB N/A
- PNI N/A
- Revenue Next Year
- CNTB N/A
- PNI N/A
- P/E Ratio
- CNTB N/A
- PNI N/A
- Revenue Growth
- CNTB N/A
- PNI N/A
- 52 Week Low
- CNTB $0.51
- PNI $6.03
- 52 Week High
- CNTB $1.60
- PNI $7.89
- Technical
- Relative Strength Index (RSI)
- CNTB 72.56
- PNI 52.86
- Support Level
- CNTB $1.05
- PNI $6.68
- Resistance Level
- CNTB $1.56
- PNI $6.78
- Average True Range (ATR)
- CNTB 0.13
- PNI 0.07
- MACD
- CNTB 0.04
- PNI 0.00
- Stochastic Oscillator
- CNTB 84.59
- PNI 71.43
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About PNI Pimco New York Municipal Income Fund II of Beneficial Interest
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.